Marinus Pharmaceuticals(MRNS) - 2022 Q3 - Quarterly Report

Table of Contents For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION COMMISSION FILE NUMBER 001-36576 WASHINGTON, D.C. 20549 MARINUS PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 20-0198082 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 ...